Injective and InQubeta Given Huge Boost, Are These October’s Top Tokens?

It’s fall and we are just two months away from ringing in the New Year. The cryptocurrency market hit the headlines in the past week with its rallying prices and has set high expectations for analysts who are hopeful of another action-packed year. Even in October, there were tokens like InQubeta (QUBE) and Injective (INJ) which led the market rally. 

While Injective’s success was expected given how it has been expanding its clientele over the years, InQubeta was the surprise that no one saw coming. Built on the Ethereum network, the platform serves as a crowdfunding resource for startups working with artificial intelligence. 

Over a few months, InQubeta has stirred interest among crypto users due to its unique use cases. It’s closing in on the fifth presale stage and has already raised more than $3.8 million. 

InQubeta: Opening a new chapter of growth for AI startups 

InQubeta is considered one of the best altcoins to buy now as it opens several doors for startups leveraging AI. These budding companies and their talented teams can foray ahead to bring their ideas to life without a funds crunch. 

Investors onboarding InQubeta get access to projects powered by cutting-edge technology like AI that puts them ahead of their contemporaries. As InQubeta’s transparent model facilitates seamless communication between startups and investors, there’s zero possibility of any fraud or unauthentic transactions.

What further boosts crypto users’ confidence in InQubeta’s potential is its native cryptocurrency which combines the efficiency of the ERC-20 standard with diverse utilities. Called the QUBE token, InQubeta’s native cryptocurrency is used for payments and also for validating transactions via staking. 

If a QUBE token holder agrees to stake their assets, they contribute towards the platform’s balanced growth. In exchange, the token holders get rewards for their contribution. 

QUBE’s unique utility has helped it outperform many top crypto coins. Consider the example of how the token is a key component of InQubeta’s governance structure. Having a decentralized governance system means that there’s no single authority making all decisions. Instead, these decisions are taken by the community as a whole. 

If a community member comes up with an idea that could potentially enhance InQubeta’s prospects, it’s pitched before all stakeholders for a discussion. Later, the proposed changes are put before QUBE token holders who are given voting privileges. Using these rights, QUBE token holders can make decisions that complement the platform’s growth. 

QUBE can help you beat market volatility and inflation so that your returns stay intact. This is made possible due to its deflationary model which regulates the token supply to tame internal inflation and minimize price fluctuations. 

Injective announces integration with Google Cloud

Injective is a blockchain network specifically designed to cater to people’s DeFi needs. The Layer 1 blockchain is interoperable and arms developers with tools to deploy a wide range of DeFi products that include dApps and lending protocols. 

Its native cryptocurrency is called INJ and is used for all transactions processed on the network. INJ is a good crypto to buy because it has a powerful code architecture that has cross-chain capabilities. Its USPs include CosWasm – an interoperable smart contracts platform – and a proof-of-stake consensus protocol for verifying transactions. 

Injective has recently announced its integration with Google Cloud, a leading provider of cloud computing services. Google Cloud users will be able to access Injective via the Analytics Hub, which is the former’s data exchange portal. 

The integration would enable enterprises and developers to tap into data across the Injective network. With the Google Cloud server, one can explore bespoke Injective datasets.

Conclusion

Given the recent gains made by Injective and InQubeta in the crypto market, it can be tough to decide which of the two is a better best crypto investment. Thankfully, we have analysts and their views to guide us. 

Analysts who have been tracking the two tokens suggest that when it comes to long-term returns, InQubeta is a better bet than Injective as it enables its token holders to build a brand new source of income while expanding their passive earnings through opportunities like staking. At the same time, it shows innovators how pioneering technologies can catalyze decentralized finance. 

Head over to the QUBE presale and get a chance to accumulate this upcoming new cryptocurrency at attractive prices and as an early buyer, you can also take advantage of exciting bonus offers!

Visit InQubeta Presale

^{Disclaimer: The statements, views and opinions expressed in this press release are solely those of the content provider and do not necessarily represent those of CoinChapter. CoinChapter will not be responsible in any way for the content of the same. Do your research and invest at your own risk.}